S&P 500   4,360.33 (+0.78%)
DOW   34,210.68 (+0.15%)
QQQ   347.15 (+1.77%)
AAPL   168.11 (+5.58%)
MSFT   303.01 (+1.06%)
FB   298.20 (+1.21%)
GOOGL   2,623.04 (+1.66%)
AMZN   2,812.89 (+0.72%)
TSLA   853.77 (+2.98%)
NVDA   224.52 (+2.31%)
BABA   112.94 (+1.03%)
NIO   21.21 (+0.47%)
AMD   104.12 (+1.48%)
CGC   7.20 (+5.11%)
MU   78.06 (-0.84%)
GE   90.17 (+0.30%)
T   24.60 (+1.99%)
F   19.50 (-0.26%)
DIS   135.89 (+0.35%)
AMC   14.43 (-0.62%)
PFE   54.36 (+1.85%)
ACB   3.91 (+3.17%)
BA   187.27 (-1.31%)
S&P 500   4,360.33 (+0.78%)
DOW   34,210.68 (+0.15%)
QQQ   347.15 (+1.77%)
AAPL   168.11 (+5.58%)
MSFT   303.01 (+1.06%)
FB   298.20 (+1.21%)
GOOGL   2,623.04 (+1.66%)
AMZN   2,812.89 (+0.72%)
TSLA   853.77 (+2.98%)
NVDA   224.52 (+2.31%)
BABA   112.94 (+1.03%)
NIO   21.21 (+0.47%)
AMD   104.12 (+1.48%)
CGC   7.20 (+5.11%)
MU   78.06 (-0.84%)
GE   90.17 (+0.30%)
T   24.60 (+1.99%)
F   19.50 (-0.26%)
DIS   135.89 (+0.35%)
AMC   14.43 (-0.62%)
PFE   54.36 (+1.85%)
ACB   3.91 (+3.17%)
BA   187.27 (-1.31%)
S&P 500   4,360.33 (+0.78%)
DOW   34,210.68 (+0.15%)
QQQ   347.15 (+1.77%)
AAPL   168.11 (+5.58%)
MSFT   303.01 (+1.06%)
FB   298.20 (+1.21%)
GOOGL   2,623.04 (+1.66%)
AMZN   2,812.89 (+0.72%)
TSLA   853.77 (+2.98%)
NVDA   224.52 (+2.31%)
BABA   112.94 (+1.03%)
NIO   21.21 (+0.47%)
AMD   104.12 (+1.48%)
CGC   7.20 (+5.11%)
MU   78.06 (-0.84%)
GE   90.17 (+0.30%)
T   24.60 (+1.99%)
F   19.50 (-0.26%)
DIS   135.89 (+0.35%)
AMC   14.43 (-0.62%)
PFE   54.36 (+1.85%)
ACB   3.91 (+3.17%)
BA   187.27 (-1.31%)
S&P 500   4,360.33 (+0.78%)
DOW   34,210.68 (+0.15%)
QQQ   347.15 (+1.77%)
AAPL   168.11 (+5.58%)
MSFT   303.01 (+1.06%)
FB   298.20 (+1.21%)
GOOGL   2,623.04 (+1.66%)
AMZN   2,812.89 (+0.72%)
TSLA   853.77 (+2.98%)
NVDA   224.52 (+2.31%)
BABA   112.94 (+1.03%)
NIO   21.21 (+0.47%)
AMD   104.12 (+1.48%)
CGC   7.20 (+5.11%)
MU   78.06 (-0.84%)
GE   90.17 (+0.30%)
T   24.60 (+1.99%)
F   19.50 (-0.26%)
DIS   135.89 (+0.35%)
AMC   14.43 (-0.62%)
PFE   54.36 (+1.85%)
ACB   3.91 (+3.17%)
BA   187.27 (-1.31%)
NASDAQ:BMRA

Biomerica News Headlines

$3.96
+0.01 (+0.25%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.77
$4.30
50-Day Range
$3.89
$5.08
52-Week Range
$3.30
$8.15
Volume
157,563 shs
Average Volume
108,759 shs
Market Capitalization
$50.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.69
Get Biomerica News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Biomerica Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMRA
News Sentiment

0.30

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMRA Articles
This Week

2

2

BMRA Articles
Average Week



Biomerica (NASDAQ:BMRA) News Headlines Today

SourceHeadline
MarketBeat logoBiomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $4.43
americanbankingnews.com - January 28 at 3:36 AM
globenewswire.com logoBiomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021 - GlobeNewswire
globenewswire.com - January 14 at 9:11 PM
benzinga.com logoBiomerica's Return On Capital Employed Overview - Benzinga - Benzinga
benzinga.com - January 13 at 3:34 PM
finance.yahoo.com logoBiomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021 - Yahoo Finance
finance.yahoo.com - January 13 at 10:34 AM
finance.yahoo.com logoBiomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
finance.yahoo.com - January 13 at 10:34 AM
MarketBeat logoBiomerica (NASDAQ:BMRA) Posts Earnings Results, Misses Estimates By $0.01 EPS
americanbankingnews.com - January 13 at 7:28 AM
benzinga.com logoBiomerica shares are trading higher after the company reported Q2 EPS and sales results were higher year-over-year. - Benzinga
benzinga.com - January 13 at 5:34 AM
benzinga.com logoBiomerica: Q2 Earnings Insights - Benzinga - Benzinga
benzinga.com - January 13 at 12:33 AM
MarketBeat logoBiomerica, Inc. (NASDAQ:BMRA) Expected to Announce Earnings of -$0.08 Per Share
americanbankingnews.com - January 7 at 4:14 PM
finance.yahoo.com logoGlobal Vacuum Blood Collection Tube Market Forecast Report 2021-2028 - Opportunities in Robust Advancements in Healthcare Facilities and Infrastructure - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - January 7 at 5:51 AM
finance.yahoo.com logoVacuum Blood Collection Tube Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Material, Application, and End User, and Geography - Yahoo Finance
finance.yahoo.com - January 6 at 6:14 PM
finance.yahoo.com logoBiomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million - Yahoo Finance
finance.yahoo.com - December 16 at 1:43 PM
finance.yahoo.com logoBiomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
finance.yahoo.com - December 16 at 1:43 PM
nasdaq.com logoShareholders Will Most Likely Find Biomerica, Inc.'s (NASDAQ:BMRA) CEO Compensation Acceptable - Nasdaq
nasdaq.com - December 3 at 8:07 AM
finance.yahoo.com logoMost Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable
finance.yahoo.com - December 3 at 8:07 AM
globenewswire.com logoBiomerica Forms Scientific Advisory Board for Colorectal Cancer Screening - GlobeNewswire
globenewswire.com - November 19 at 9:00 AM
baystreet.ca logoBiomerica Vaults on Patent News - Baystreet.ca
baystreet.ca - November 8 at 7:40 PM
globenewswire.com logoBiomerica Receives Notice of Allowance from Canadian Patent - GlobeNewswire
globenewswire.com - November 4 at 6:44 PM
finance.yahoo.com logoBiomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment
finance.yahoo.com - November 4 at 8:06 AM
finance.yahoo.com logoBiomerica Launches New Website for Its Aware® Breast Exam Device
finance.yahoo.com - October 29 at 8:25 AM
marketwatch.com logoBiomerica Shares Down After Walmart Begins Sales of EZ Detect Screening Test - MarketWatch
marketwatch.com - October 22 at 12:34 AM
seekingalpha.com logoBiomerica rises as Walmart begins instore selling of cancer test - Seeking Alpha
seekingalpha.com - October 19 at 2:44 PM
globenewswire.com logoWalmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test - GlobeNewswire
globenewswire.com - October 19 at 9:44 AM
finance.yahoo.com logoWalmart to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Screening Test
finance.yahoo.com - October 19 at 9:44 AM
benzinga.com logoThe Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO - Benzinga
benzinga.com - October 17 at 11:26 PM
globenewswire.com logoBiomerica Reports Results for Fiscal First Quarter ended August 31, 2021 - GlobeNewswire
globenewswire.com - October 16 at 10:55 AM
finance.yahoo.com logoBiomerica Reports Results for Fiscal First Quarter ended August 31, 2021 - Yahoo Finance
finance.yahoo.com - October 15 at 9:07 AM
finance.yahoo.com logoBiomerica Reports Results for Fiscal First Quarter ended August 31, 2021
finance.yahoo.com - October 15 at 9:07 AM
streetinsider.com logoForm 10-K/A BIOMERICA INC For: May 31 - StreetInsider.com
streetinsider.com - October 14 at 11:06 PM
benzinga.com logo5 Short Squeeze Candidates To Watch: Bit Digital, Camber Energy Rejoin The List - Benzinga
benzinga.com - October 12 at 1:28 PM
nasdaq.com logoWe're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate - Nasdaq
nasdaq.com - October 12 at 8:27 AM
finance.yahoo.com logoWill Biomerica (NASDAQ:BMRA) Spend Its Cash Wisely?
finance.yahoo.com - October 12 at 8:27 AM
seekingalpha.com logoUpHealth, Biomerica, Grom Social Enterprises among premarket losers' pack - Seeking Alpha
seekingalpha.com - October 5 at 10:13 AM
benzinga.com logo5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays - Benzinga
benzinga.com - October 4 at 12:32 PM
businessinsider.com logo5 Short-Squeeze Stocks to Buy Like GameStop or AMC - Fintel - Business Insider
businessinsider.com - October 4 at 7:32 AM
nasdaq.com logoBMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today - Nasdaq
nasdaq.com - October 3 at 1:30 AM
finance.yahoo.com logoAnalysts Laud Five9 Post Zoom Deal Termination - Yahoo Finance
finance.yahoo.com - October 2 at 3:38 AM
finance.yahoo.com logoMid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
finance.yahoo.com - October 1 at 10:37 PM
benzinga.com logo12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga - Benzinga
benzinga.com - October 1 at 12:36 PM
nasdaq.com logoHealth Care Sector Update for 10/01/2021: MRK, ZOM, BMRA, WMT, XLV, IBB - Nasdaq
nasdaq.com - October 1 at 12:36 PM
investorplace.com logoBMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today - Investorplace.com
investorplace.com - October 1 at 12:36 PM
thestreet.com logoBiomerica Stock Soars; Walmart Sells Colorectal-Screening Test - TheStreet
thestreet.com - October 1 at 12:36 PM
streetinsider.com logoBiomerica, Inc. (BMRA) Announces Walmart Now Selling its EZ Detect Colorectal Screening Test - StreetInsider.com
streetinsider.com - October 1 at 7:20 AM
globenewswire.com logoWalmart Now Selling Biomerica's EZ Detect™ Colorectal Screening Test - GlobeNewswire
globenewswire.com - October 1 at 7:20 AM
finance.yahoo.com logoWalmart Now Selling Biomerica’s EZ Detect™ Colorectal Screening Test
finance.yahoo.com - October 1 at 7:20 AM
seekingalpha.com logoNeovasc shares jump 15% on FDA approval of COSIRA-II Reducer trial - Seeking Alpha
seekingalpha.com - September 17 at 1:51 PM
seekingalpha.com logoCorvus Pharmaceuticals, Innate Pharma lead healthcare gainers; Protagonist Therapeutics, TCR2 Therapeutics among major losers - Seeking Alpha
seekingalpha.com - September 17 at 1:51 PM
seekingalpha.com logoIs Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022 - Seeking Alpha
seekingalpha.com - September 15 at 1:52 PM
benzinga.com logoBiomerica Says Expects Completion Of Patient Enrollment For InFoods Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week - Benzinga
benzinga.com - August 30 at 5:50 PM
globenewswire.com logoBiomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical - GlobeNewswire
globenewswire.com - August 30 at 5:50 PM
Get Biomerica News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMRA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.